About Contact Us Careers
Sign In

Acromegaly Treatment Market Analysis

  • Report ID: 2696
  • Published Date: Oct 16, 2024
  • Report Format: PDF, PPT

Acromegaly Treatment Market Analysis

The acromegaly treatment market is segmented by disease type, treatment, route of administration, distribution channel, and region. Among treatment segmentation,  the medication segment is projected to drive the global market. Factors such as the efficiency of drugs, non-invasive treatments, lesser side effects than radiation therapies, and strong pipeline portfolio are likely to strengthen the growth of the overall market globally.

Our in-depth analysis of the global market includes the following segments:

By Disease Type
  • Ectopic Acromegaly
  • Pseudo Acromegaly

By Treatment
  • Medication 
    • Somatostatin analogs
    • Dopamine agonists
    • Growth hormone receptor antagonists
    • Others
  • Radiotherapy
  • Surgery

By Route Of Administration
  • Oral
  • Parenteral

By Distribution Channel
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Others
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 2696
  • Published Date: Oct 16, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of acromegaly treatment is assessed at USD 2.26 billion.

Acromegaly Treatment Market size was over USD 2.16 billion in 2023 and is projected to reach USD 4.33 billion by 2036, growing at around 5.5% CAGR during the forecast period i.e., between 2024-2036.

North America industry is predicted to dominate majority revenue share by 2036, attributed to factors such as availability of reimbursement, favorable government policies, an increase in the occurrence of pituitary tumors leading to acromegaly and gigantism, technological advancements, and rising awareness among people around the diagnosis of the disease in the region.

The major players in the market are Chiasma Inc., Novartis AG, Ipsen Biopharmaceuticals Inc, Wockhardt., Troikaa Pharmaceuticals Ltd., VHB Life Sciences Limited, GlaxoSmithKline plc., Amryt Pharma plc, Antisense Therapeutics Limited, and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample